510(k) K791749

INDIRECT IMMUNO ENZYME,ANTIGEN,CONTROL by Clinical Sciences, Inc. — Product Code DAA

K791749 is an FDA 510(k) premarket notification submitted by Clinical Sciences, Inc. for the device "INDIRECT IMMUNO ENZYME,ANTIGEN,CONTROL". The FDA issued a decision of Substantially Equivalent on Oct 17, 1979. The device falls under product code DAA (Igg, Peroxidase, Antigen, Antiserum, Control), a Class II device regulated under 21 CFR 866.5510. Clinical Sciences, Inc. has 29 other 510(k) clearances on record.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
Oct 17, 1979
Date Received
Sep 10, 1979
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device classification

Device Name
Igg, Peroxidase, Antigen, Antiserum, Control
Device Class
Class II
Regulation Number
866.5510
Review Panel
PA
Submission Type
510(k)

Need the full FDA record for Clinical Sciences, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: FDA 510(k) database entry for K791749. Report a data issue: hello@regdatalab.com.